XJPX
4229
Market cap174mUSD
Oct 09, Last price
4,190.00JPY
1D
0.84%
1Q
-9.41%
Jan 2017
25.83%
Name
Gun Ei Chemical Industry Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gun Ei Chemical Industry Co., Ltd., together with its subsidiaries, manufactures and sells synthetic resins and fibers in Japan and internationally. It operates through three segments: Chemicals Business, Food Business, Real Estate Utilization Business. The company offers RESITOP for photoresist, reactive polyimide, phenolic resins, and high purity bisphenol F, which are used in electronic materials; Resitop for shell molding; NFURAN, which is used for curing of furan resin by acids as catalyst; a-system, a self-curing mold production system; and AR SAND that offers sand filling efficiency and mold strength. It also provides functional phenolic resin, kynol novoloid fibers, spherical phenolic resins, s-RP nano sand, high purity bisphenol F, and Milex special phenolic resin that are used in industrial materials. In addition, the company provides foods, such as starches and sugars; and business outsourcing and staffing services. Further, it involved in the leasing of real estate. Gun Ei Chemical Industry Co., Ltd. was founded in 1946 and is headquartered in Takasaki, Japan.
Key people
Yoshikazu Arita
Chairman of the Board, Representative Director · since 2016
Mitsuhiro Arai
Executive Officer, Chief Director of Sales & Marketing, Director · since 2025
Akihiro Okubo
Executive Officer, Chief Director of Development · since 2018
Takeshi Tsuihiji
Executive Officer, Chief Director of Manufacturing · since 2021
Kiichiro Arita
Executive President, Chief Executive Officer, Representative Director · since 2018
Isao Kasahara
Director · since 2024
Katsuhiro Maruyama
Executive Officer, Chief Director of Corporate, Director · since 2021
Independent Director · since 2021
Independent Director · since 2021
Hiroko Suzuki
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||